Tpp-CAQK TFA binds to mitochondria, facilitating the creation of Mito-Tpp-CAQK TFA, an engineered mitochondrial compound with excellent bioactivity. It's internalized by macrophages, enhancing myelin debris phagocytosis, alleviating mitochondrial dysfunction, and reducing proinflammatory profiles, ultimately aiding tissue repair and functional recovery in mice after spinal cord injury.
- Home
- Solutions
- By Disease
- Systemic Mitochondrial Disease
- Alpers Disease
- Barth Syndrome
- Carnitine Deficiency
- Creatine Deficiency Syndromes
- Co-Enzyme Q10 Deficience
- Friedreich’s Ataxia
- Kearns-Sayre Syndrome
- Lactic Acidosis
- Leigh Syndrome
- Mitochondrial DNA Depletion Syndrome
- MELAS Syndrome
- Multiple Mitochondrial Dysfunction Syndrome
- Short-Chain Acyl-CoA Dehydrogenase Deficiency
- Thymidine Kinase 2 Deficiency
- Mitochondrial Neurogastrointestinal Encephalopathy
- Organ-specific Mitochondrial Diseases
- Systemic Mitochondrial Disease
- By Applications
- Mitochondrial Disease Diagnostics Service
- Therapeutics Development Services for Mitochondrial Diseases
- Mitochondrial Disease Target Development & Identification Service
- Mitochondrial Disease Model Development Service
- Drug Development Service for Mitochondrial Diseases
- In Vitro Mitochondrial Analysis Service
- In Vivo Mitochondrial Fission and Fusion Analysis
- By Molecular Type
- By Disease
- Products
- Mitochondrial Isolation Reagents & Kits
- Mitochondrial Staining Reagents & Kits
- Mitochondrial Disease Diagnostic Reagents & Kits
- Biochemical Inhibitors & Activators
- Mitochondrial Specific Antibodies
- Mitochondrial Recombinant Proteins
- Mitochondria Related Peptides
- Natural Products Targeting Mitochondria
- Resource
- About Us
- Contact Us
- Careers